FLUZONE HIGH-DOSE

Product Overview

About FLUZONE HIGH-DOSE

FLUZONE HIGH-DOSE is a trivalent inactivated influenza vaccine, designed to provide protection against three strains of the influenza virus: HAEMAGGLUTININ-STRAIN A (H3N2), HAEMAGGLUTININ-STRAIN A (H1N1), and HAEMAGGLUTININ-STRAIN B. This vaccine is intended for individuals 65 years of age and older, as well as younger individuals with certain health conditions, to help prevent influenza infection and its associated complications.

Key Benefits & Uses

• Prevention of influenza infection caused by HAEMAGGLUTININ-STRAIN A (H3N2), HAEMAGGLUTININ-STRAIN A (H1N1), and HAEMAGGLUTININ-STRAIN B.
• Protection against influenza-related complications, such as pneumonia and bronchitis.
• Reduced risk of hospitalization and death due to influenza infection.

Active Ingredient & Action

FLUZONE HIGH-DOSE contains inactivated HAEMAGGLUTININ-STRAIN A (H3N2), HAEMAGGLUTININ-STRAIN A (H1N1), and HAEMAGGLUTININ-STRAIN B viruses, which stimulate the body's immune system to produce antibodies that help protect against future influenza infections. The high-dose formulation is designed to provide a stronger immune response in older adults and individuals with certain health conditions.

Important Notes

FLUZONE HIGH-DOSE should be administered by a healthcare professional, typically in the fall or early winter, to provide optimal protection against influenza infection during the upcoming flu season. It is essential to follow the recommended dosing schedule and to report any adverse reactions or concerns to a healthcare professional.